Michael Cannon of the Cato Institute on Reducing Drug Prices

Michael Cannon is the Director of Health Policy Studies at the Cato Institute. We'll discuss President Trump's executive order that aims to reduce American (prescription) drug prices.

Michael F. Cannon | Cato Institute

Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients – The White House

Trump executive order gives drugmakers 30-day deadline to lower drug costs | AP News

Trump's drug price plan: Why it may not amount to much change

Trump drug price order puts new pressure on pharma

It was interesting to hear RFK Jr praise Trump for implementing a Bernie Sanders policy proposal. Is that really what a Republican president, even a populist like Trump, wants to hear?